Honokiol protects pancreatic β cell against high glucose and intermittent hypoxia-induced injury by activating Nrf2/ARE pathway in vitro and in vivo
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 97, 1229-1237
Abstract
No abstract availableKeywords
Funding Information
- Science Foundation of Tianjin Medical University China (2016KYZQ12)
This publication has 38 references indexed in Scilit:
- Independent Association Between Obstructive Sleep Apnea Severity and Glycated Hemoglobin in Adults Without DiabetesDiabetes Care, 2012
- Sleep fragmentation and intermittent hypoxemia are associated with decreased insulin sensitivity in obese adolescent Latino malesPediatric Research, 2012
- Leukotriene B4 Receptor-1 Mediates Intermittent Hypoxia-induced AtherogenesisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalencePopulation Health Metrics, 2010
- Peroxiredoxin III protects pancreatic β cells from apoptosisJournal of Endocrinology, 2010
- Oxidative Folding: Cellular Strategies for Dealing with the Resultant Equimolar Production of Reactive Oxygen SpeciesAntioxidants & Redox Signaling, 2009
- Different Redox States in Malignant and Nonmalignant Esophageal Epithelial Cells and Differential Cytotoxic Responses to Bile Acid and HonokiolAntioxidants & Redox Signaling, 2009
- Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic β‐cell replication in miceThe Journal of Physiology, 2008
- Intermittent Hypoxia Causes Insulin Resistance in Lean Mice Independent of Autonomic ActivityAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Intermittent Hypoxia Increases Insulin Resistance in Genetically Obese MiceThe Journal of Physiology, 2003